Insights AI News How memristor-based artificial neuron could link to brain
post

AI News

17 Mar 2026

Read 17 min

How memristor-based artificial neuron could link to brain

Memristor-based artificial neuron operates at biological voltages to enable low-energy cell links.

Scientists built a memristor-based artificial neuron that fires at living-cell voltages and listens to chemical cues, letting electronics talk to tissue. It creates clean spikes near 0.1 volts, resets itself, and reacts to sodium and dopamine. Early tests show real-time links with heart cells and point to low-power wearables. Engineers have long wanted electronics that speak the same electrical language as our bodies. Natural neurons use tiny voltage swings and timed spikes. Many past chips needed louder signals, so they could not sit close to cells without drowning them out. A team at UMass Amherst has now made a low-voltage neuron circuit that matches the body’s rules and can read real tissue signals in real time. It is fast, frugal, and sensitive to chemistry, not just electricity. The heart of the design is a biological material inside a special switch called a memristor. That choice helps it fire at the same levels as living cells and reset itself, like a true spike. This work shows a clear path for tighter links between soft tissue and hard chips. It also shows how simple, low-power circuits could shrink future patches or implants. The tests include live heart cells and key brain chemicals, which is a strong step toward safe neural interfaces. The paper appears in Nature Communications and comes from the lab of Jun Yao at UMass Amherst.

Why matching voltage changes the game

Most neurons fire in the 70–130 millivolt range. That is a very small nudge. Many artificial neurons need five to ten times more voltage and much more power. These higher levels force designers to add amplifiers, filters, and cables. Each extra part adds heat, delay, and failure risk. By dropping the firing level near 0.1 volts, the new circuit can sit close to cells and watch them directly. That means:
  • Less power loss, since the circuit does not waste energy boosting tiny signals
  • Less signal damage, since the circuit does not overwhelm nearby cells
  • Cleaner data, since the device listens where the action is
  • Simpler designs, since bulky front-end amplifiers may not be needed
  • Lower voltage also reduces heat. Heat harms tissue and shortens the life of implants. A low-voltage spike that still has the right timing and shape is a key step toward safe, stable links.

    Inside the memristor-based artificial neuron

    The central switch in this circuit is a memristor. A memristor is a tiny element whose resistance depends on its past current. It can “remember” and then reset, which fits the spike-and-recover behavior of a neuron. The team tuned this part with protein nanowires made by the microbe Geobacter sulfurreducens. These nanowires conduct electrons and help the device switch on at low voltages.

    The bacterial nanowire switch

    The memristor turns on near 60 millivolts at currents of just a few nanoamps. It then turns itself off again rather than latching. That self-reset is important. A spike should be brief. After a spike, a neuron needs a short rest, called a refractory period. The memristor’s natural turn-off creates that pause without extra logic. This gives the circuit a stable rhythm that tracks how real neurons behave. The use of Geobacter nanowires is smart for two reasons:
  • They enable switching at biologically relevant voltages
  • They avoid large currents that would stress cells
  • This blend of biology and electronics allows the device to sit inside the cell’s operating window and stay there.

    How the circuit spikes and resets

    A simple capacitor works with the memristor to shape the spike. Here is the flow:
  • The memristor switches on when the input crosses its low threshold
  • The capacitor charges fast, which creates a sharp output pulse
  • As charge builds, the circuit forces the memristor to switch back off
  • The output falls to near zero, and a short rest follows
  • This sequence blocks the output from smearing into a flat plateau. Each event is a clean burst with a start, a peak, and an end. One artificial neuron can trigger the next, which supports small networks rather than only single-shot demos.

    Listening to chemistry, not just electricity

    Your brain is not just a wire. It is also a soup. Chemicals called neuromodulators change how likely a neuron is to fire. Two common examples are sodium ions and the neurotransmitter dopamine. The new circuit can sense and respond to both. It uses graphene-based sensors and other elements to detect these cues and adjust its timing.

    Sodium speeds the rhythm

    Sodium ions play a core role in action potentials. When sodium levels rise, the device shortens its reset time and fires more often. This is close to how real neurons become more excitable in sodium-rich conditions. The circuit therefore does not only copy the spike shape. It also responds to the same knobs that biology turns.

    Dopamine tunes the gain

    Dopamine has a two-way effect in the system, depending on dose. At some levels, it increases activity. At others, it eases or dampens firing. This mirrors the nuanced way dopamine affects circuits in the brain. A device that can register these differences can fit into mixed chemical and electrical environments, where simple on/off logic fails. These chemical controls matter for future therapy. Many brain disorders involve shifts in neuromodulators. If a device hears and adapts to those shifts, it could avoid fighting the body and may work with it.

    Talking with living cells in real time

    To test real tissue, the team grew cardiomyocytes—heart muscle cells—on a soft graphene mesh. These cells beat by sending small electrical signals through the sheet. The mesh recorded both the tiny voltages and the motion of contraction. During normal beats, the device stayed quiet. When the team sped up the cells with a drug, the circuit fired in response. This shows that the device can sit next to living tissue and respond on the spot to real signals, without large amplifiers in the loop. It is not yet a brain test, and the authors do not claim that. But heart cells prove that the method works with living, pulsing tissue. That is a big step. The next phase will test nerve cells and organoids. Those tests will check long-term stability and show how well the spikes travel in a network.

    What this means for wearables and implants

    Today, many wearables run tiny bio-signals through big amplification and filtering chains. Each stage burns battery. Each cable or chip adds bulk. If a sensor can digest neuron-level inputs directly, the system can be smaller, cooler, and simpler. Here are likely gains:
  • No or fewer front-end amplifiers for biopotentials
  • Lower battery drain and less heat near the skin
  • Slimmer patches that are more comfortable and discreet
  • Faster response because there are fewer stages to process
  • Think of a skin patch that can pick up nerve spikes in your arm and trigger a haptic cue in real time. Or an implant that rests next to a small cluster of neurons and adapts to local dopamine shifts. A memristor-based artificial neuron makes these visions more practical by aligning with biology’s voltage and chemistry.

    Energy, size, and fabrication advantages

    The device uses far less energy than past chemical-sensitive artificial neurons. The authors report at least a 100× energy cut in some chemical modes compared with earlier designs. The circuit in its lean form also strips away extra sensing blocks, while keeping the same spike energy. That means less silicon area and simpler routing. Just as important, the approach is friendly to standard chip-making processes. When a design fits common fabrication steps, it can scale faster from lab to pilot lines. That increases the chance that we will see early medical and consumer trials sooner. Key practical points include:
  • Low-voltage spiking near 0.1 V
  • Nanoamp-level switching currents
  • Sustained self-reset behavior for stable rhythms
  • Graphene and protein nanowires that integrate with microfabrication
  • Each point reduces the gap between a cool demo and a product that runs all day on a small battery.

    Limits, open questions, and next steps

    The results are promising, but many steps remain between a benchtop prototype and a clinical device. Open questions include:
  • Long-term stability: Do the nanowires and memristors drift over months or years?
  • Biocompatibility: How do tissues respond over time to graphene, nanowires, and packaging?
  • Noise and variability: How does the device handle real-world motion, sweat, and temperature shifts?
  • Scalability: Can arrays of these neurons stay synchronized without cross-talk?
  • Closed-loop control: Can the device both listen and safely stimulate in a feedback loop?
  • The next logical studies will pair the circuit with neurons from the brain or spinal cord. Teams will need to show that recorded spikes are stable, that stimulation is safe, and that chemical sensing remains accurate. Trials in animal models will test whether arrays can decode and influence behavior. Battery life, wireless links, and safe enclosures will round out the system design.

    How it fits into the future of computing

    Most computers use digital logic. Brains use spikes, timing, and chemistry. This device does not try to force the brain to speak binary. It meets biology where it lives. That choice can pay off for edge computing, where sensors must be close to the source, frugal, and responsive. Possible application paths:
  • Prosthetics that use nerve signals to control motion with low latency
  • Closed-loop pain therapy that adapts to local chemical signals
  • Seizure detection that runs directly on scalp or cortical signals
  • Smart patches that track muscle fatigue and tremor without heavy processing
  • Beyond health, such circuits could help machines read plants, microbes, or organ-on-chip systems. Anywhere a device must interpret weak electrical and chemical cues, a low-voltage spiking unit adds value.

    From lab insight to design playbook

    One reason this study stands out is its match across many axes at once: voltage, power, timing, chemistry, and network behavior. Past efforts often showed one or two of these traits, but not all. By aligning with biology on several fronts, the design gives engineers a clear playbook:
  • Use a low-threshold memristor for spike onset
  • Add a capacitor to shape a clean, short pulse
  • Exploit the device’s own reset path for a refractory period
  • Layer in chemical sensors so the spike rate follows neuromodulators
  • Target signals from tissue without external amplification
  • This playbook can guide teams who build new interfaces for nerves, hearts, and glands. It also opens ways to mix spiking units with classic digital chips. For example, a skin patch could use spiking front-ends to compress signals at the edge, and then send compact events to a microcontroller for higher-level logic. In the lab tests here, the circuit already shows that it can process neuron-level signals pulled straight from living systems. That proof reduces risk for product teams and helps move the field from theory to practice. The work also reminds us to respect the body’s scale. If we want our devices to integrate well, they should act more like cells, not like power tools. Quiet signals, brief pulses, and chemistry-aware behavior make that possible. The path ahead will require careful studies and strict safety checks. But this result points to a future where electronics and biology share not just space but also rules. That is how we get devices that heal, restore, and enhance without fighting the systems they touch. In short, this research shows how a memristor-based artificial neuron can align with living cells on voltage, timing, and chemistry. With further testing, it could become a building block for gentle, efficient neural interfaces that listen and respond the way our bodies do.

    (Source: https://www.earth.com/news/first-artificial-neuron-capable-of-communicating-with-the-human-brain/)

    For more news: Click Here

    FAQ

    Q: What is a memristor-based artificial neuron and how does it differ from earlier artificial neurons? A: A memristor-based artificial neuron uses a memristor tuned with bacterial protein nanowires to switch at biologically relevant voltages and produce brief, self-resetting spikes. Unlike earlier artificial neurons that required much higher voltages and far more power, this design matches the voltage, timing, energy, and chemical sensitivity of living neurons. Q: Why is matching the low voltage of biological neurons important for device-tissue communication? A: Biological neurons fire in the roughly 70–130 millivolt range, so matching those low voltages avoids overwhelming cells and reduces the need for bulky amplification. Operating near 0.1 volts lets circuits sit close to tissue with less heat and lower power consumption. Q: How does the memristor produce spikes and enforce a refractory period in the circuit? A: In this memristor-based artificial neuron the memristor switches on at a low threshold (about 60 millivolts and nanoamp-level currents), a capacitor charges to create a sharp output pulse, and the memristor then resets as charge builds to end the spike. That self-reset creates a brief refractory period so each burst returns near zero instead of smearing into a long signal. Q: What roles do the bacterial nanowires and graphene sensors play in the device? A: Protein nanowires from Geobacter sulfurreducens tune the memristor so it switches at biologically relevant voltages, while graphene sensors detect chemical cues such as sodium and dopamine. Together these elements let the circuit respond to both electrical signals and the chemical context around living tissue. Q: Has this device been tested with living cells, and what were the outcomes? A: Researchers linked the circuit to cardiomyocytes grown on a soft graphene mesh and recorded real-time responses to the cells’ electrical activity. The device remained quiet during normal beats but produced spikes when a drug sped up the cells’ rhythm, demonstrating communication with living tissue without large amplifiers. Q: Could a memristor-based artificial neuron be used in wearables or implants soon? A: The low-voltage, low-power design could reduce or eliminate front-end amplification, enabling smaller, cooler, and more energy-efficient patches or implants. However, the current prototype is a benchtop demonstration and needs further testing for long-term stability, biocompatibility, and safety before clinical use. Q: What are the main technical challenges that must be addressed before clinical or commercial use? A: Key open questions include long-term stability of the nanowires and memristors, tissue biocompatibility, handling noise and motion-related variability, and scaling arrays without cross-talk. Teams also need to show safe closed-loop control, consistent chemical sensing over time, and successful tests with nerve tissue and animal models. Q: How might this technology change computing and medical applications if fully developed? A: By matching voltage, timing, and chemistry, a memristor-based artificial neuron could enable edge devices that interpret weak biological signals directly and support applications like prosthetics, closed-loop therapies, seizure detection, and smart patches with lower latency and power use. Broad adoption still depends on further tests, fabrication scaling, and proof that arrays can operate stably in real-world conditions.

    Contents